The determination of von Willebrand factor activity in the plasma of dogs. 1. Experimental evaluation and methods
Jurina, K.; Gropp, F.; Oechtering, G.
Tierarztliche Praxis 24(6): 616-620
1996
ISSN/ISBN: 0303-6286 PMID: 9139430 Document Number: 459910
Using a new aggregometer, the plasma activity of von Willebrand factor (vWF) in dogs was measured. The method is described. It has the advantage of being more precisely for the diagnosis of von Willebrand's disease than the determination of von Willebrand antigen (vWF: Ag) by using an ELISA. With the method described reproducible and reliable result can be obtained.
Document emailed within 1 workday
Related Documents
Lu, G-yuan.; Shen, L.; Wang, Z-yue.; Guo, X-fang.; Bai, X.; Su, J.; Ruan, C-geng. 2008: Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases Chinese Medical Journal 121(2): 133-136Arnold, S.; Mueller, A.; Binder, H.; Meyers, K.; Giger, U. 1997: Von Willebrand factor concentrations in blood plasma of Bernese mountain dogs Schweizer Archiv für Tierheilkunde 139(4): 177-182
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Cucuianu, M.; Trif, I.; Roman, S.; Manasia, M.; Spînu, C.; Cristea, A. 1989: Plasma von Willebrand factor antigen and activity and platelet aggregability in patients with proteinuria Medecine Interne 27(4): 263-271
Rastegar-Lari, G.; Ajzenberg, N.; Ribba, A.S.; Vereycken-Holler, V.; Legendre, P.; Villoutreix, B.; Meyer, D.; Baruch, D. 2001: Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations Thrombosis and Haemostasis 86(6): 1459-1465
Brinkhous, K.M.; Thomas, B.D.; Ibrahim, S.A.; Read, M.S. 1977: Plasma levels of platelet aggregating factor/vom Willebrand factor in various species Thrombosis Research 11(3): 345-355
Takaki, A. 1974: Evaluation of three methods for plasma fibrinogen determination Rinsho Byori. Japanese Journal of Clinical Pathology 22(8): 533-538
Takahashi, H. 1981: Studies on the pathophysiology and treatment of von Willebrand's disease. II. Gel filtration studies on plasma factor VIIi in von Willebrand's disease Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 44(1): 165-172
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Girma, J.P.; Pietu, G.; Lavergne, J.M.; Meyer, D.; Larrieu, M.J. 1982: Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease Journal of Laboratory and Clinical Medicine 99(4): 481-494
Brassard, J.A.; Meyers, K.M. 1994: Von Willebrand factor is not altered in azotemic dogs with prolonged bleeding time Journal of Laboratory and Clinical Medicine 124(1): 55-62
Kajikawa, M.; Kuramoto, J. 1979: Determination of von Willebrand factor Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl: 2210-2211
Ockelford, P.A.; Lowe, G.; Johns, A.S.; Berry, E.W. 1986: Comparison of methods of plasma volume determination for dose calculation of factor VIII in patients with classic haemophilia New Zealand Medical Journal 99(796): 116-119
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Ito, S.; Takaoka, T.; Nakaya, Y.; Hiasa, Y.; Mori, H.; Tanaka, K.; Ichihara, A. 1982: Clinical value of the determination of serum guanase activity. Studies on patients and experimental data from mongrel dogs and cultured rat hepatocytes Gastroenterology 83(5): 1102-1108
Triolo, G.; Giardina, E.; Casiglia, D.; Scarantino, G.; Bompiani, G.D. 1991: Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor Clinical and Experimental Immunology 84(1): 53-58
Meyer, D.; Obert, B.; Pietu, G.; Lavergne, J.M.; Zimmerman, T.S. 1980: Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease Journal of Laboratory and Clinical Medicine 95(4): 590-602
Pei, P.; Cigler, C.; Vonderschmitt, D.J. 1991: Evaluation of enzymatic methods for the determination of plasma sodium and potassium using the Hitachi 747 analytic system Schweizerische Medizinische Wochenschrift 121(50): 1883-1886
Baluda, M.V.; Baluda, V.P.; Novikova, I.V.; Deianov, I.I.; Timofeeva, A.V.; Fomina, V.M.; Filonov, V.K.; Emtseva, V.P. 1990: Willebrand's factor, functional activity of blood platelets and antiaggregation activity of the vascular wall in ischemic heart disease Sovetskaia Meditsina 11: 7-9
Dowling, S.V.; Ekert, H. 1976: A comparison of two methods for measurement of von Willebrand's factor (ristocetin cofactor) Thrombosis and Haemostasis 36(1): 284-285